The historic mutual rise of prenatal ultrasonography and autism spectrum disorder and their similarities and controversies in the literature are discussed in this review.
exposing fetuses to X-rays was not found to be harmful until it was linked to the development of childhood leukemia decades later. This paper seeks to establish a need to further study these attributes of prenatal ultrasound overuse and their possible impact on a developing fetus, with a special focus on the occurrence of Autism.
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Introduction:
The prevalence of autism spectrum disorder (ASD) has been rising markedly since the Centers for Disease Control and Prevention (CDC; Atlanta, GA, USA) first began recording its prevalence in 1988. 1 There is no known cause for ASD; regardless, the coinciding rise in abdominal prenatal ultrasonography (PUS) use and prevalence of ASD is challenging to disregard. However, any possible correlation between the two has not been well-explored. This review focuses on excessive PUS usage and ASD development.
History of PUS
Ultrasonography was first used in the field of obstetrics/gynecology in 1958 2 .Bang and Holm 3 in
1968, reported identifying a fetal heartbeat at ten weeks of gestation. In the early 1980s, an "ultrasonic boom" 4 ensued because of the introduction of a small, portable, and affordable ultrasonic real-time device that facilitated PUS examinations in the doctors' clinics worldwide. 5 Ultrasonography involves pressure waves that are greater than 20 kilohertz in frequency to make ultra-oscillating sound waves that penetrate tissue as mechanical energy. 6, 7 The contact between the ultrasonic wave and the scanned tissue produces the following biophysical effects: thermal effects, cavitation, and acoustic pressure flow in body fluids. The intensity of an ultrasonic wave (i.e., the acoustic power per unit of area) is measured in milliwatt per square centimeter (mW/cm 2 ).
The highest exposure intensity within the beam (i.e., spatial peak) is averaged over the time of exposure (i.e., temporal average) and is named the spatial peak temporal average. [6] [7] [8] [9] [10] After ultrasound manufacturers developed output display standard (ODS) biosafety measures by displaying their levels on the ultrasonic screens, the Food and Drug Agency (FDA) in 1992 deregulated the acoustic output levels of clinical ultrasound systems, which produced better images and therefore improved diagnosis for patients. Ultrasonic acoustic output levels, emitted by the transducer, for fetal, neonatal, and pediatric imaging were augmented from 94 mW/cm 2 in 1986 11 to 720 mW/cm 2 in 1992, 12 including the peak exposure through the mechanical index, which enhanced potential biophysical effects exerted on the embryo and fetus. 4, 6, 10, 13 The ODS is composed of two indices to alert the end-user of temperature rise and mechanical impact. The soft tissue thermal index depends on three factors: transducer opening i.e. beam width, beam direction, and scanning mode. The ultrasonic beam can produce heat 6, 7, 10 and cause hyperthermia 6,9-11 to an embryo/fetus. The mechanical or cavitation index occurs because of an intense beam forming bubbles in soft tissue; if severe, mechanical injury causes cavitation in tissues. 14 The acoustic output leads to radiation forces flowing in fluids causing strain on tissues. 15 The responsibility of the ultrasonographer is to keep these indices as low as possible and to maintain the acoustic pressure as low as reasonably achievable (ALARA). These safety regulations are clinician-and end-user-dependent. 11, 13 Hence, the FDA recommended that ultrasound scanning be limited for valid medical indications and conducted by the professionally trained end-users. 11, 13, 15 In the 1980s, the first diagnostic imaging devices evolved into a digital two-dimensional (2D) arrays. This advancement was followed, in the 1990s, by real-time processable threedimensional (3-D) and four-dimensional (4-D) arrays, which is 3-D visualization with motion.
15,16

History of ASD
In 1943, child psychiatrist Kanner 17 was the first to characterize autism as extreme social isolation and intolerance for change; he used the term "autos," meaning "self" in Greek, to describe "early infantile autism." Kanner also emphasized the rarity of infantile autism with 150 cases per 20,000 "troubled children" observed over a 30-year career.
In 1944, Asperger 18 described autistic-like behavior in young boys with decreased social and communicative interactions combined with ordinary intelligence and language attainment. In 1966, an epidemiological survey in the County of Middlesex by Lotter 19 revealed that the prevalence of "autistic" cases was 4.5 per 10,000 population and was more common in boys.
In 1970, Treffert 20 of the state of Wisconsin in the United States published a 5-year study (conducted from 1962 to 1967) that investigated the prevalence of infantile autism, which was rare at a prevalence of 0.7 cases per 10,000 population. In the Treffert study, the ordinal position of the autistic child was not the firstborn male. The total prevalence of infantile autism in addition to childhood psychosis and psychotic disorders with brain damage was 4.8 cases per 10,000 population, which was similar to Lotter's figures of prevalence rates.
Prevalence of ASD
ASD has undergone various diagnostic modifications; [21] [22] [23] [24] [25] [26] however, the prevalence of ASD grew exponentially and globally within the last 50 years, as presented in the following 
Prenatal Ultrasonography and ASD
Although an "ultrasound boom" 61 coincided with an "autistic epidemic," 44, 62 correlation and causation between the two has yet to be investigated empirically.
In 2010, in a retrospective American study of children born from 1995 to 1999, Grether et al. 63 found that ultrasonic exposure in the second trimester of pregnancy was not a risk factor for ASD.
In 2012, Stoch et al. 64 from Australia examined an existing controlled study to evaluate the correlation between childhood ASD diagnosis and randomized prenatal ultrasonic exposure. Of 2,834 randomly selected single pregnancies, 1,415 pregnancies underwent one ultrasonic scan at 18 weeks of gestation whereas 1,419 pregnancies underwent several second-and third-trimester scans at 18, 24, 34, and 38 weeks. ASD rate did not show a significant variation between a single second-trimester scan versus several ultrasound scans in the second and third trimesters.
In 2016, Carlsson et al. 65 from Sweden analyzed the frequency of ASD in 30,000 children born from 1999 -2003. In the study, 14,726 single pregnancies were randomly exposed to one ultrasonic scan at 12 weeks of gestation, and 14,596 pregnancies were exposed to several ultrasonic scans at 18, 24, 34, and 38 weeks of gestation. There was no significant difference in the ASD occurrence between early and late PUS exposure. 4. Use as short as possible exposure time (no longer than 5-10 min), not exceeding 60 minutes.
12,66
The acoustic output threshold was defined; therefore, the AIUM and other societies incorporated the "as low as reasonably achievable" (i.e., "ALARA") principle in its guidelines to monitor and maintain the acoustic output.
67-70
The Triple Hit Hypothesis ASD varies from mild to severe disease. Casanova explains this spectrum in the "triple hit" hypothesis 71, 72 wherein the development of autism is determined by the different interaction of three factors: the vulnerable stage of brain development, genetic susceptibility, and environmental impact such as ultrasonic exposure primarily during the first trimester. Casanova hypothesized that the severity of ASD depends on the timing, duration, and intensity of PUS scanning to the embryo/fetus.
In July 2016, Webb et al. 73 retrospectively analyzed a modification of Casanova's hypothesis by analyzing a possible association between ASD severity and PUS exposure within the first trimester of pregnancy with fetuses genetically predisposed to ASD. Genetic predisposition was determined, based on the presence or absence of ASD-associated copy number variations (CNVs) with structural duplications or deletions of deoxyribonucleic acid (DNA) base pairs in the genome sequence. 74 The results of the Webb et al. 73 study supported the hypothesis that male ASD children with
CNVs, who were exposed to first-trimester ultrasound, had a considerably reduced non-verbal intelligence quotient and more repetitive behaviors than male ASD children with CNVs without ultrasound exposure. It also demonstrated that first-trimester PUS exposure influences the outcome diversity in ASD children, whether CNVs were present or not. This variation was not associated with social affective impairment but increased parental reports of repetitive behaviors.
The study suggested that the diversity in ASD symptoms may partially result from ultrasonic exposure during early prenatal development in children with particular genetic susceptibilities.
The AIUM Bioeffects Committee 75 responded to Webb's 73 study, by emphasizing that the study results did not determine a causal relationship between ultrasound use and autism. It advocated that PUS can be safely performed by qualified sonographers and clinicians for valid medical causes, and PUS exposure can be reduced when the ALARA principle is applied. Brightness modulation (B-mode) scanners, used in the mid-1990s, are the source of the prevalent safety verification of PUS. 10, 65, 79, 81 The new devices such as pulsed Doppler, color flow, or scanners produce 10-to 15-fold higher acoustic outputs than those of the earlier 1990s scanners;
Safety of PUS
however, there is a shortage of epidemiological biosafety studies on the new devices' usage. 79,81 82 Left-handedness, speech delays, dyslexia are PUS-associated neurological symptoms. [80] [81] [82] The hypothesis is that PUS generated heat may raise the maternal core temperature. Thus, thermal heat cannot dissipate due to the lack or poorly developed blood circulation in the embryo/fetus respectively, inactivating fetal core enzymes. cm in the mean depth of ultrasonic penetration was observed in the ASD group compared to both the neurotypical and developmentally delayed groups. The higher mean depth of penetration denotes that greater than expected heat dissipation occurred at 3.5-megahertz transducer frequency and has affected fetal neural tissue development in ASD patients. 71, 102, 103, 132 Ten years after the implementation of ODS, a Swedish assessment 86 revealed that 33% of daily PUS end-users could comprehend the mechanical and thermal indices, 28% were aware of the location of safety indices on their screen, and merely 22% could modify the energy output on their machine. The inadequate knowledge of end-users of the biosafety indices or their screen appearance is widespread among medical professionals in many countries.
86-89
The current clinical practice is to scan all pregnant women who have low-or high-risk pregnancies at every prenatal clinic visit, which may amount to 10 scans per pregnancy. 10, 76, 77 Souvenir or keepsake fetal ultrasounds has expanded into a major industry and are conducted by nonmedical personnel. [90] [91] [92] [93] The FDA 94 
and the European Committee for Medical
Ultrasound Safety, 95 strongly deter this nonmedical practice.
Risk Factors of ASD
Advanced parental age and a higher age difference between parents have been linked as ASD risk factors. 96 ASD risk is also increased in the offspring of mothers with systemic lupus erythematosus, 97 diabetes mellitus, 98, 99 pre-eclampsia, 100 and influenza virus infection or vaccination during pregnancy. 101 Antepartum, intrapartum and perinatal complications were identified as ASD risk factors; including birth asphyxia with Apgar scores of <7 at 5 minutes after birth. 102, 103 The association between prenatal fever and ASD, as demonstrated in the studies by Brucato 104 and Hornig, 105 can be an indirect warning of the temperature rise in the embryo/fetus when exposed to an undetected high thermal index during ultrasonography.
Genetics and ASD
The association between ASD and genetics is vastly studied. The genome-wide screening for ASD susceptibility loci, [106] [107] [108] has linked more than 100 genomic loci with ASD.
ASD comprises certain genetic syndromes, yet gene penetrance varies within a population. For example, the autistic features of fetal valproate syndrome affect approximately 10% of individuals, whereas those of Angelman's syndrome affect 80% of individuals. However, gene mutations in autism are rare and occur in <1% of the population. 110 Twin studies revealed that ASD has moderate genetic heritability and is significantly influenced by environmental factors. 111 Only 5%-15% of ASD cases are identified, based on genetic variations. 112 Genetic variations are involved in ASD; however, geneticists agree that a significant environmental effect is also associated with it. 106, 112 They commend investigating other nongenetic causes of ASD.
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Neurodevelopment in ASD
Normal neurodevelopment extends from embryogenesis to late adolescence; yet, its critical embryonic/fetal neurodevelopmental growth is susceptible to environmental injuries. 113 The neurotypical brain attains 70% and 80% of its adult mass by one and two years of age, respectively.
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Neurodevelopmentally ASD demonstrates two variations: (1) the course of the autistic brain development deviates from the neurotypical one, 71, [115] [116] [117] and (2) the diversity in ASD neuroanatomy depends on the severity of the autistic disorder. 115, 117 Magnetic resonance imaging (MRI), both functional and structural, is a noninvasive modality for research in children. 118, 119 MRI research studies are not applicable before the diagnostic confirmation of ASD at 2-4 years of age. Head circumference measurements correspond accurately with the brain volume, based on structural MRI imaging in 1.7-year-old to 6-year-old normal children but not in the older age group. 121 Three stages of ASD brain development exist. The first stage is verified by means of head circumference measurements. 116, 121 The last two stages are confirmed by using longitudinal serial structural MRI. Stage I
At birth, ASD newborns may have a normal or less than the 25 th percentile head circumference.
The growth of the head circumference/brain size subsequently accelerates to the 84 th percentile in the first two years of life. 116, [121] [122] [123] These changes are predominantly in the dorsolateral prefrontal cortex with an abnormal increase in the frontal and temporal lobe and amygdala. 124 In ASD, the overgrowth of the head circumference/brain size (i.e., macrocephaly) is one of the most frequent traits of the severe form of ASD. [122] [123] [124] [125] Stage II At 6-10 years of age, the ASD brain's growth rate gradually decelerates to a plateau with the ultimate cessation of growth, which reduces the cortical thickness and brain volume. 126 These early changes affect the growth of brain architecture, and neural connectivity.
126,12
Stage III At 10-15 years of age, the brain growth rate in ASD intersects that of the growth percentile of neurotypical adolescents. 128 A prompt decline subsequently ensues in ASD brain volume and continues rapidly throughout late adolescence and adulthood with diminution of cortical thickness and ultimately cortical atrophy.
127-130
Neuropathology of ASD
Embryonic/fetal neural development depends on vital sequential and genetic programming of the brain. 131 Individuals with the neurodevelopmental HOXA1 gene, which is associated with autism, 132 have a large head circumference. This finding confirms the significance of macrocephaly as a clinical sign of ASD.
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To determine whether the overgrowth of the young autistic brain is because of poor control of neuron production (i.e., dysregulation) or lack of cell death (i.e., apoptosis), Courchesne et al. 133 performed neuron cell counts in the postmortem prefrontal cortices. The study showed a 67% increase in neurons in seven autistics versus six normal males. In the dorsolateral and mesial segments of the ASD prefrontal cortex, the increase was 79% and 29%, respectively.
Prenatally, cortical neurons develop; therefore, this large number of neurons produced in the frontal cortex can only occur because of an abnormal prenatal event that may result in a gene defect or a neural deformity and may delineate the primary biologic etiology of ASD.
Postnatally, neurological development is incapable of producing such excessive frontal lobe neurons. [123] [124] [125] 133, 134, 138 In the ASD frontal lobe of the cerebral cortex, diffusion tensor imaging outlines reduced connections in the white matter association tract as well as horizontal commissural tracts connecting the two hemispheres, and vertical project tracts connecting the brainstem and the spinal cord, based on high values for the apparent diffusion coefficient in the whole frontal lobe. [135] [136] [137] Ribonucleic acid (RNA) in situ hybridization markers reveal abnormal architecture and cortical disorganization in the prefrontal and temporal cortex in autistic children. A prenatal developmental dysfunction may cause this disorganization in neuronal layer formation and differentiation. 138 Neuropathologically, cortical gray matter was embedded in the white matter with multiple developmental defects in 92% of the brains of autistic patients. 139 The amygdala is a cluster of nuclei in the temporal lobe 140 that regulates emotions such as fear, gratification, anger, and hostility. Dysfunctional amygdala causes lack of social interaction and absence of facial and emotional reaction in ASD. 141 Amygdalar volume growth in ASD is increased in early toddlerhood; however, it eventually slows down such that the neuronal cell number and size are reduced in adulthood. 117, 142 Amygdalar enlargement is associated with intense apprehension, and deterioration of communication and social abilities.
142,143
The cerebellum contributes to higher cognitive functions, such as language, cognitive, and emotional adaptation, 144, 145 in addition to balance and motor function.
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In ASD children, diffusion tensor imaging 146, 147 depicts abnormal connectivity between the cerebellar pathways and its rostral protrusion, where the cerebellar-cerebral disconnection is augmented by the reduced volume, 148 number and density 149 of the Purkingie cells which results in the behavioral and cognitive features of ASD. 150, 151 Recent MRI cerebellar studies [152] [153] [154] show that autistic children have reduced cerebellar vermal volumes of lobes VI and VII. These findings are particular to nonsyndromic ASD.
Vargas et al. 155 reported a pathological inflammation in the cerebral cortices, white matter, and cerebella of ASD patients, supported by proinflammatory cytokines in the ASD cerebrospinal fluid. The ASD postmortem reports of age-specific changes in the weight and volume of brain are probably due to an impediment in its development that causes a continuous inflammatory process.
Discussion
In 1966, before the advent of the portable sonogram, the incidence of ASD was 3 to 4 patients per 10,000 population. 19 By 2004, although various diagnostic criteria were implemented, the incidence had increased to 30-40 patients per 10,000 population. 156, 157 A literature review indicates a surge in the prevalence of ASD, which has affected an estimated 1% of all age groups among high-income countries. 44, 56 In addition to the increased prevalence in ASD, the use of PUS has significantly increased. 61, 158 The association of radiographic imaging during pregnancy and childhood leukemia was only established by MacMahon in 1962-forty years since the beginning of radiographic imaging. 159 In 2013, the evaluation of randomized data of PUS usage from insurance sources revealed an average of 4 -5 prenatal scans per pregnancy with a 30%-50% increase in the utilization rate. In 2015, the economic burden of ASD in the United States was forecasted to be $268 billion;
1.45% of the gross domestic product. By 2025, the economic burden is forecasted to increase to $461 billion; which will be 2.29% of the gross domestic product. 161 The global disease burden of ASD was estimated at 9 million years lived with disabilities by 2016;
121 disability-adjusted life years per 100,000 population. Studies have demonstrated excessive neuron production throughout the first two years of life in ASD patients. It is hypothesized that this is due to an aberrant prenatal event in the uterine environment. 83, 115, 116, 122, 126, 133, 134 Maternal infection during pregnancy, through maternal immune activation (MIA) dysregulation, may alter brain development programming during embryonic/fetal life. 134 The tendency to conduct a PUS scan for every prenatal visit, which mostly involve low-risk pregnancies, is not medically indicated and is contrary to the American College of Obstetrics and Gynecology (ACOG) and AIUM safety guidelines. 69, 70 A PUS viability scan at 8-10 weeks of gestation should take a very brief dwell time. A second scan to evaluate morphology at 22-24 weeks of gestation ought to be as short as possible.
The medical history for all prenatal visits necessitates the acquisition of information regarding previous PUS scans, and patients must be cautioned to avoid commercial ultrasounds. The maternal temperature should be recorded prior to and during if ultrasonic scanning time is prolonged. 163 The mother must provide informed signed consent before undergoing PUS scanning. When ultrasonically scanning the patient, the ultrasonographer is required to monitor and to document the number of scans, the thermal and mechanical indices, the acoustic output, the depth of penetration and the dwell time.
Regulatory reforms must be implemented to improve professional end-users' knowledge and modification of ultrasonic biosafety parameters. Medical ultrasonographers must acquire a license, which is to be renewed periodically, through strict training with a practical examination. [85] [86] [87] [88] [89] The popular practice of commercial fetal video scanning of pregnant women, [90] [91] [92] [93] should be prohibited for maternal and fetal safety.
Maternal blood biomarkers such as cell-free DNA 164 are available to test for aneuploidy and to replace ultrasonic nuchal translucency examinations which may take up to 45 minutes to uphold the fetus in the military position.
The study by Rosman et al. 84 regarding the association of prenatal ultrasonography and ASD is an essential step in the research on the impact of PUS usage on the fetus; however, casecontrolled studies have limitations.
Although ASD research has focused on genetics, medical, and environmental causes, and delineated multiple risk factors and associations; a definite etiology of ASD has yet to be identified.
Prenatal ultrasonography, an important obstetrical tool, is not a commercial commodity and its usage needs to be medically indicated and restricted to safeguard the lives of our future children.
Conclusion
The long-term PUS biophysical effects 6,7 on the embryo/fetus featuring the acoustic output of new ultrasonic devices, 15, 16, 85 its overuse in clinical practice 10, 77 and the commercial fetal video souvenirs [91] [92] [93] [94] remain unknown.
A joint obstetric/pediatric, peer-reviewed, statistically significant study to determine whether a correlation prevails between excessive in utero ultrasonic exposure and the development of childhood ASD is long overdue.
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